<DOC>
	<DOCNO>NCT00938964</DOCNO>
	<brief_summary>The purpose study see drug call lidocaine prevents cognitive injury ( decline mental ability ) heart surgery . Lidocaine currently FDA approve commonly use treat heart rhythm disorder regional anesthesia ( block nerve ) . The investigator enrol subject research project see lidocaine reduce high incidence cognitive injury see heart surgery . As part study , investigator also evaluate relationship cognitive injury genetic makeup chemical change subject blood surgery .</brief_summary>
	<brief_title>Lidocaine For Neuroprotection During Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<criteria>1 . CABG , CABG + Valve , Valve surgery 2 . Use cardiopulmonary bypass 1 . Less 50 year age 2 . History diabetes 3 . History symptomatic cerebrovascular disease ( e.g . prior stroke ) residual deficit 4 . Alcoholism ( &gt; 2 drinks/day ) 5 . History psychiatric illness ( clinical diagnosis require therapy ) 6 . History drug abuse ( illicit drug use past 3 month ) 7 . Hepatic insufficiency ( liver function test &gt; 1.5 time upper limit normal ) 8 . Severe pulmonary insufficiency ( require home oxygen therapy ) 9 . Renal failure ( baseline serum creatinine &gt; 2.0 mg/dl ) 10 . Pregnant woman 11 . Unable read thus unable complete cognitive test 12 . Score &lt; 24 baseline Mini Mental State examination ( MMSE ) great equal 27 baseline Center Epidemiological Studies Depression ( CESD ) Scale</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Cognition</keyword>
</DOC>